Munoz, C., Juarez, G., Munoz, M., Portnow, J., Fineman, I., Badie, B., Mamelak, A., Ferrell, B. The quality of life of patients with malignant gliomas and their caregivers.  Social Work in Health Care 47(4): 455-478, 2008.

Luu, T., Morgan, R., Leong, L., Lim, D., McNamara, M., Portnow, J., Frankel, P., Smith, D., Doroshow, J., Gandara, D., Aparicio, A., Somlo, G., Wong, C.  A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium study.  Clin Cancer Res 2008;14(21), 2008.

Xiao G, Zhou B, Somlo G, Portnow J., Juhasz A, Un F, Chew H, Gandara D, Yen Y.  Identification of F-box/LLR-repeated Protein 17 as Potential Useful Biomarker for Breast Cancer Therapy.  Cancer Genomics & Proteomics 5: 151-160, 2008.

Portnow J.,  Treatment of primary CNS lymphoma – which one is best?  Amer. J. Oncol. Rev 3 (5): 286-289, 2004.

Portnow, J., Lim, C., and Grossman, S.A.  Assessment of pain caused by invasive procedures in cancer patients.  J. Natl. Comprehensive Cancer Network 1(3): 435-439, 2003.

Portnow, J., Suleman, S., Grossman, S.A., Eller, S., and Carson, K.  A cyclooxygenase-2 (COX-2) inhibitor compared with dexamethasone in a survival study of rats with intracerebral 9L gliosarcomas.  Neuro-Oncology 4(1): 22-25, 2002.

Portnow, J. and Grossman, S.A.  Pain - Mechanisms, Assessment and Management.  In Cancer and the Skeleton.  G.R. Mundy and R.D. Rubens, eds., Martin Dunitz, London, c. 2000.

This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 03/09.